GSK plc

Stocks

GSK

GB00BN7SWP63

Market Closed - London S.E. Other stock markets 11:35:17 2026-07-14 am EDT			5-day change	1st Jan Change
1,920.50 ^GBX	-1.69%		-4.12%	+5.26%

11:06am	Where would AI lead Pharma in the long run?
Jul. 13	European Equities Mixed in Monday Trading; Eni to Fuel BMW Corporate Fleets With Renewable Diesel	MT

Transcript : GSK plc Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 11

Published on 06/03/2026 at 05:21 pm EDT

S&P Capital IQ

Add MarketScreener to your sources

Presenter Speech
Michael Leuchten (Analysts)

It's my pleasure to introduce GSK. We've got Hesham, he's the Head of Oncology R&D at GSK. Exciting times just coming out of ASCO. I guess, Hesham, thank

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Add MarketScreener to your sources

Latest news about GSK plc

11:06am	Where would AI lead Pharma in the long run?
Jul. 13	European Equities Mixed in Monday Trading; Eni to Fuel BMW Corporate Fleets With Renewable Diesel	MT
Jul. 13	UK's FTSE 100 Flat as US-Iran Tension Resurfaces	MT
Jul. 13	GSK : UBS remains Neutral	ZD
Jul. 13	GSK Plc Announces Positive Interim Results From AZUR-1 Phase II Trial Of Jemperli In dMMR/MSI-H Locally Advanced Rectal Cancer	CI
Jul. 13	GSK Says Jemperli Poised to Transform Rectal Cancer Care After Positive Interim Trial Results	MT
Jul. 13	GSK Says Mid-Stage Trial of Jemperli Met Main Goal in Rectal Cancer	MT
Jul. 13	GSK posts encouraging data for bowel cancer treatment Jemperli	AN
Jul. 13	Oil gains lift BP as Iran tensions weigh	AN
Jul. 13	GSK's Jemperli meets main goal in mid-stage rectal cancer trial	RE
Jul. 13	GSK hails cancer trial success; Plus500 backs outlook	AN
Jul. 13	GSK Reports Positive Interim Data for Jemperli in Mid-stage Rectal Cancer Trial	MT
Jul. 13	GSK's cancer drug Jemperli meets main goal in mid-stage rectal cancer trial	RE
Jul. 13	GSK : JP Morgan remains a Sell rating	ZD
Jul. 13	UK Stocks-Factors to watch on July 13	RE